By Andrey Darenberg, founder, RateYourCyber.com – Generative AI has moved through financial services faster than most internal governance frameworks were designed to absorb. What began as experimentation inside research and technology teams is now embedded across investment analysis, due diligence,
The Mandatum Managed Futures fund was named winner of the UCITS Performance of the Year: Multi-Strategy at the Hedgeweek® European Awards 2026. Senior portfolio manager Ville Rantanen outlines what sets the fund apart and how the fund captured crisis alpha
Francesco Parella, founder and CEO/CTO of AlgoTraders, named Outsourced Trading Provider of the Year at the Hedgeweek® European Awards 2026, outlines how the firm provides a one-stop solution for handling of all quantitative trading needs and helps managers improve the
Amitis Capital Digital provides diversified exposure to leading opportunities across the digital assets ecosystem. Chief Strategy Officer Adil Abdulali outlines how the strategy aims to capture both market beta and differentiated alpha by allocating to a curated portfolio of best-in-class
As part of our series profiling portfolio managers at Wellington Management, Hedgeweek® sat down with Aaron Yunis, who is now running a directional rates and FX strategy in New York
Private real estate capital has grown increasingly sophisticated over the past decade. However, many fund managers still lack a working understanding of the legal and regulatory frameworks that govern their structures. For emerging managers in particular, that gap between what
As part of our series profiling portfolio managers at Wellington Management, Hedgeweek® sat down with Frederico Lupi, who has just been appointed to the industrials division in London.
The role of independent directors has evolved into one of strategic importance in demonstrating governance best practice, writes Geoff Ruddick (pictured), Hawksford Managing Director and Country Head – Cayman Islands.
Hedgeweek® spoke with Dean Schaffer, CEO of Lightkeeper, a data provider that transforms investment data into high value intelligence.
Small- and mid-cap biotechnology have rebounded sharply after three years of sustained contraction. Following the COVID-era bubble, biotech stocks experienced a peak-to-trough drawdown of roughly 60%. In 2025, after an initial decline of over 20 per cent, the sector is
